[Essential conditions for the development of new anticancer drugs based on ICH-GCP].
Saijo
N
N
D000970:Antineoplastic Agents; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D007258:Informed Consent; D007564:Japan; D009369:Neoplasms / Q000628:therapy*; D011795:Surveys and Questionnaires
D000970:Antineoplastic Agents